Company Filing History:
3 out of 3,871 
1 out of 164 
1 out of 38 
Years Active: 2014-2018
Title: Robin Lee: Innovator in Lipid Nanoparticle Technology
Introduction
Robin Lee is a distinguished inventor based in San Diego, CA, known for his groundbreaking contributions to the field of drug delivery systems. With a total of four patents registered, Lee has made significant strides in the development of lipid nanoparticles, which play a crucial role in enhancing the efficacy of various therapeutic agents.
Latest Patents
Among his latest innovations, Robin Lee has developed a method for producing lipid nanoparticles specifically designed for drug delivery. This advanced method focuses on creating liposomes that efficiently encapsulate negatively charged therapeutic polymers, such as siRNA. The process involves preparing a lipid mixture containing a cationic lipid in a water-miscible organic solvent, such as ethanol, at a concentration of 2.3 mg/ml. Subsequently, this mixture is added to a polymer dissolved in water, resulting in a final ethanol concentration of 35% in water. The final charge ratio of the drug to lipid is maintained at 1:2.5, yielding nanoparticles with a mean size ranging from 50 to 150 nm. This innovative approach enhances the delivery and stability of therapeutic agents, marking a significant advancement in the field.
Career Highlights
Robin Lee has held key positions in prominent companies during his career. Notable among these are Nitto Denko Corporation and Amylin Pharmaceuticals, Inc., where he contributed his expertise in lipid formulation and drug delivery systems. His work has garnered recognition and played a vital role in pushing the boundaries of pharmaceutical innovations.
Collaborations
Throughout his career, Robin has collaborated with noteworthy professionals, including Victor Knopov and Richard P. Witte. These partnerships have fostered an environment of creativity and innovation, leading to significant advancements in the technology surrounding lipid nanoparticles and their applications in medicine.
Conclusion
In summary, Robin Lee's contributions to the field of drug delivery through his innovative methods for producing lipid nanoparticles are undeniable. With four patents to his name and a track record of collaboration with esteemed colleagues, Lee continues to pave the way for future advancements in pharmaceutical technologies. His work not only enhances the effectiveness of therapeutic substances but also holds the potential to improve patient outcomes in various medical treatments.